Your position:m.limatoxi.com >> EN >> EN >> Formulation >> Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials >> article
 
Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials
Editor:xuezhe     Clicks:0    Date:2023-1-12 13:49:54
Keyword: Luoqi Biotech LQ043H
Healthoo Information:
Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Top Biotechnology Financing List Released! Two Chinese Pharmaceutical ...
  • VC price from main domestic suppliers
  • Vitamin C export statistics in first hal...
  • Taiwan eyes biotech cooperation with China
  • Gaoke Vitamin C item passed environmental&nbs...
  • Tiger Biotech to build the project of&nb...
  • Tiger Biotech to expand vitamin C capaci...
  • Shanghai makes large investment into biotechn...
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map